# Federal Register #DEA-1783

DEA controlled-substance importer and bulk-manufacturer registration applications

**Buyer:** Drug Enforcement Administration
**Posted:** October 19, 2026
**Respond By:** December 18, 2026
**Identifier:** DEA-1783

The DEA notice concerns applications to import or bulk-manufacture controlled substances for research and product development, rather than a purchase solicitation.
- **Government buyer / issuing agency:** U.S. Department of Justice, Drug Enforcement Administration (DEA); no specific office is identified.
- **Named organizations:** **University of Mississippi’s National Center for Natural Products Research (NCNPR)**, Groff Health Inc., Halo Pharmaceutical Inc., and Organic Standards Solutions International, LLC. The excerpt does not identify Organic Standards Solutions International’s substances or application details.
- **Applicant activities and substances:**
  - Groff Health Inc. seeks importer registration for ibogaine (7260), 3,4-methylenedioxymethamphetamine (7405), psilocybin (7437), and psilocyn (7438), for internal research, clinical trials, analytical purposes, and customer distribution.
  - **University of Mississippi’s NCNPR** seeks bulk-manufacturer registration for marihuana (7360), marihuana extract (7350), and tetrahydrocannabinols (7370), for product development and reference standards. The extract and tetrahydrocannabinols would be derived from marihuana.
  - Halo Pharmaceutical Inc. seeks importer registration for psilocybin (7437), for formulation development and clinical trials.
- The listed substances are Schedule I controlled substances. No purchase quantities, products or services for sale, or performance period are specified.

### Description

The National Center for Natural Products Research University of Mississippi/NCNPR applied to register as a bulk manufacturer of controlled substances. The application covers marihuana extract, marihuana, and tetrahydrocannabinols. The organization plans to manufacture the substances for product development and reference standards; marihuana extract and tetrahydrocannabinols are to be extracted from marihuana. Comments, objections, or hearing requests may be submitted on or before December 18, 2026.

[View original listing](https://www.federalregister.gov/documents/2026/10/19/2026-21359/bulk-manufacturer-of-controlled-substances-application-national-center-for-natural-products-research)